Featured Publications
An Analysis of Benzodiazepine Prescribing to Primary Care Patients in a Large Healthcare System from 2019-2020
Weleff J, Anand A, Squeri M, Sieke R, Thompson N, Barnett B. An Analysis of Benzodiazepine Prescribing to Primary Care Patients in a Large Healthcare System from 2019-2020. Journal Of Psychoactive Drugs 2023, 56: 245-256. PMID: 36940298, DOI: 10.1080/02791072.2023.2191610.Peer-Reviewed Original ResearchConceptsBenzodiazepine prescribingBenzodiazepine prescriptionsPrimary care visitsPrimary care patientsPrimary care providersEffect sizePrimary care settingPost-lockdownBenzodiazepine prescribing ratesMultivariate logistic regressionCare visitsCare providersCare settingsPrescription receiptRetrospective cohort studyCare patientsRacial disparitiesPrescribing ratesNational ratesHealthcare systemAdult patientsDiagnosis codesCocaine use disorderCohort studyPrescribing
2023
Prescribing of Z-Drugs With and Without Opioid Coprescribing to Primary Care Patients in a Large Health Care System From 2019-2020.
Anand A, Weleff J, Thompson N, Barnett B. Prescribing of Z-Drugs With and Without Opioid Coprescribing to Primary Care Patients in a Large Health Care System From 2019-2020. The Journal Of Clinical Psychiatry 2023, 84 PMID: 37707315, DOI: 10.4088/jcp.22m14753.Peer-Reviewed Original ResearchConceptsZ-drug prescribingDiagnosis of opioid use disorderZ-drug prescriptionsOpioid use disorderZ-drugsHealth care systemPrimary care clinicsWhite raceUse disorderCare systemAssociated with increasing ageCare clinicsOlder ageStudy periodDiagnosis of bipolar disorderCross-sectional studyPrimary care patientsLarger health care systemAdult patientsPatient populationOpioidGeneralized anxiety disorderPatientsBipolar disorderPost-lockdownThree Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD
Kovacevich A, Weleff J, Claytor B, Barnett B. Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD. Journal Of Psychoactive Drugs 2023, 55: 672-679. PMID: 37650700, DOI: 10.1080/02791072.2023.2253538.Peer-Reviewed Original ResearchConceptsLysergic acid diethylamidePsychedelic useOlfactory impairmentOlfactory improvementClassic psychedelic useCOVID-19-related anosmiaSerotonergic effectsIncreased neuroplasticityAnti-inflammatory effectsNaturalistic useAcid diethylamideOlfactory dysfunctionMicrosmiaPsilocybinRespiratory infectionsPsilocybin mushroomsTherapeutic benefitAnosmiaNovel treatmentReport improvementImpairmentPotential mechanismsBiological plausibilityGrowing bodyWomen